Wecome Pharmaceutical Co Ltd (300878) — Cash Flow Quality Index
Wecome Pharmaceutical Co Ltd (300878) has a Cash Flow Quality Index of -0.51x as of September 2024. Operating cash flow of CN¥-15.34 Million is below net income of CN¥29.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore 300878 current and non-current assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wecome Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2022)
Historical Cash Flow Quality Index for Wecome Pharmaceutical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Wecome Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Wecome Pharmaceutical Co Ltd (2013–2022)
Year-by-year earnings quality comparison for Wecome Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Wecome Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.25x | CN¥146.57 Million | CN¥45.12 Million | ▲ +562.9% |
| 2021 | -0.70x | CN¥-67.74 Million | CN¥96.55 Million | ▼ -322.4% |
| 2020 | 0.32x | CN¥42.81 Million | CN¥135.70 Million | ▼ -64.7% |
| 2019 | 0.89x | CN¥112.76 Million | CN¥126.01 Million | ▼ -25.6% |
| 2018 | 1.20x | CN¥105.57 Million | CN¥87.78 Million | ▲ +294.6% |
| 2017 | 0.30x | CN¥29.00 Million | CN¥95.16 Million | ▼ -75.4% |
| 2016 | 1.24x | CN¥100.15 Million | CN¥80.85 Million | ▲ +109.1% |
| 2015 | 0.59x | CN¥29.63 Million | CN¥50.02 Million | ▼ -75.8% |
| 2014 | 2.45x | CN¥46.01 Million | CN¥18.77 Million | ▲ +35.7% |
| 2013 | 1.81x | CN¥25.98 Million | CN¥14.38 Million | — |